The global cochlear implant market is anticipated to reach USD 2.77 billion by 2030, growing at a CAGR of 6.02% during the forecast period, according to a new report by Grand View Research, Inc. Hearing loss is a major concern caused by genetic factors, infections, and medications. Favorable reimbursement policies, minimally invasive procedures, and technological advancements are boosting the adoption of cochlear implants.
The increasing approvals of cochlear implants, owing to technological advancements, is expected to boost the market’s growth. For instance, in December 2020, Advanced Bionics LLC, a U.S. subsidiary of Sonova, received FDA approval for Naida CI Marvel and Sky CI Marvel sound processors in the United States. These sound processors allow users to customize their implants with the help of machine learning algorithms, based on the wearers’ location whether in noisy places or at homes.
Increasing investment in R&D activities for product innovation enables manufacturers to compete with other players to achieve a greater market stronghold. For instance, Cochlear Ltd. increased its investment to USD 199.5 million in 2021 from USD 25.9 million in 2020 . Kanso 2 sound Processor, Nucleus 7 Sound Processor, and custom sound pro fitting software by Cochlear Ltd. are some of the product launched in 2020.
Moreover, several initiatives are being undertaken by governments and various organizations to support research in the field of cochlear implantation. For instance, in March 2022, the ACI Alliance members shared their research and clinical practice at the AAA conference in 2022. The conference aimed to connect with peers, stay updated with upcoming information, and know about recent developments in the audiological industry. This is expected to boost the market’s growth.
Request a free sample copy or view report summary: Cochlear Implant Market Report
Based on age group, the adult segment dominated with the largest revenue share of 57.70% in 2023. This can be attributed to the presence of a large patient population, lower complications compared to complications in children, and availability of several products.
Based on end-use, the clinics segment held the largest revenue share in 2023. This can be attributed to the implantation procedures increasingly being performed in outpatient clinics.
North America dominated the market in 2023, attributed to technological advancements, reimbursement coverage, and greater spending capacity, resulting in high adoption of cochlear implant devices.
Asia Pacific is expected to grow at the fastest CAGR during the forecast period. This can be attributed to the rapidly increasing geriatric population coupled with rising awareness about hearing aids and the local presence of key players in the region.
Some prominent market players include Cochlear Ltd, Sonova, MED-EL Medical Electronics, Demant A/S, Zhejiang Nurotron Biotechnology Co. Ltd., and Amplifon S.p.A. (GAES)
In February 2023, Cochlear Ltd. partnered with Amazon.com, Inc. to expand audio streaming for hearing aids to provide comfortable entertainment for people with Cochlear's hearing implants.
Grand View Research has segmented the global cochlear implant market based on age group, end-use, and region:
Cochlear Implant Age Group Outlook (Revenue, USD Million, 2018 - 2030)
Adult
Adult Unilateral Implants
Adult Bilateral Implants
Pediatric
Pediatric Unilateral Implants
Pediatric Bilateral Implants
Cochlear Implant End-use Outlook (Revenue, USD Million, 2018 - 2030)
Clinics
Hospitals
Others
Cochlear Implant Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Thailand
South Korea
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Cochlear Implant Market
Cochlear Ltd.
Sonova
MED-EL Medical Electronics
Demant A/S
Zhejiang Nurotron Biotechnology Co., Ltd. (Nurotron)
Amplifon S.p.A. (GAES)
"The quality of research they have done for us has been excellent..."